Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Blister-Pack Mandate Tops Gottlieb's Agenda With New Authority

Oct 22 2018

• By Derrick Gingery

Emptyblisterpack_1200x675

Related Content

Opioid Prescribing Guidelines Put US FDA In Unfamiliar Territory

Oct 04 2018

US FDA Sets Generic Approval Record, But Generic Sponsors Aren't Celebrating

Oct 12 2018

US FDA Chief Gottlieb Envisions Tiered Mandates For Opioid Training System

Feb 19 2018

PhRMA’s Defensive Move On DTC Ads: Putting Drug List Prices ‘In Context’

Oct 16 2018

DTC Advertising: The 'Kick Me' Sign On Big Pharma’s Backs

Oct 17 2018

Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products

Sep 19 2018

Opioid Approvals: Congress Wants US FDA Guidance On Abuse Potential

Oct 01 2018

Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling

Dec 12 2017

Additional Topics

United States FDA Regulation Pricing Debate Neurology BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.